Operating Lease, Right-of-Use Asset of Arbutus Biopharma Corp from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arbutus Biopharma Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Arbutus Biopharma Corp Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $0, a 100% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Arbutus Biopharma Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $0 -$1,144,000 -100% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $0 -$1,237,000 -100% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $0 -$1,327,000 -100% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $1,048,000 -$368,000 -26% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $1,144,000 -$358,000 -24% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $1,237,000 -$348,000 -22% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $1,327,000 -$338,000 -20% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $1,416,000 -$328,000 -19% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $1,502,000 -$319,000 -18% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $1,585,000 -$337,000 -18% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $1,665,000 -$342,000 -17% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $1,744,000 -$348,000 -17% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $1,821,000 -$353,000 -16% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,922,000 -$303,000 -14% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $2,007,000 -$308,000 -13% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $2,092,000 -$313,000 -13% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $2,174,000 -$317,000 -13% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $2,225,000 -$350,000 -14% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $2,315,000 -$342,000 -13% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $2,405,000 -$333,000 -12% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 $2,491,000 -$326,000 -12% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,575,000 -$326,000 -11% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $2,657,000 -$424,000 -14% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $2,738,000 +$2,738,000 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $2,817,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $2,901,000 30 Jun 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 $3,081,000 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.